A COVID-19 protocol review committee has been established to enhance the research that is being performed at Mount Sinai and ensure that we can provide resources to accommodate as many meritorious studies as possible by minimizing redundancies and competition for finite resources and promoting team science and collaboration.
The E-Consent Electronic Consenting Platform is now available for free, at no cost for all clinical research projects.
Archive of COVID-19 related town hall meetings.
The Mount Sinai Imaging Research Warehouse (MS-IRW), developed by the BioMedical Engineering and Imaging Institute (BMEII) provides de-identified imaging data along with corresponding health records for over 1 million Mount Sinai patients.
The CAP is a very large, carefully curated dataset encompassing longitudinal patient data from numerous lung cancer, prostate cancer, and multiple myeloma cases in the Mount Sinai Health System.
OHDSI ATLAS is a web-based integrated platform for database exploration, standardized vocabulary browsing, cohort definition, and population-level analysis that can be used to query an industry-standard OMOP database sourced from the Mount Sinai Data Warehouse (MSDW).
Mount Sinai has a duty to protect the confidentiality and integrity of Protected Health Information (PHI) as required by law and professional ethics, and for accreditation requirements.
Institutional Animal Care and Use Committee (IACUC) application submission.
The TriNetX platform allows researchers to query a subset of the Mount Sinai Data Warehouse to identify cohorts, access feasibility, and design protocols. It can be used to perform de-identified queries using MSDW data.
Agreements can not be signed by ISMMS investigators. Agreements are legally binding and must be signed by an authorized ISMMS Signatory Official. Refer to the list of Agreement Types to determine which ISMMS office is required to review and negotiate your agreement.